- Department of Cardiac Surgery/Intensive Care, Real E Benemérita Associação Portuguesa de Beneficência, São Paulo, Brazil
- Department of Neurosurgery, Atenas School of Medicine, Passos, Brazil
- Department of Nanotechnology, Brain4care, São Paulo, Brazil
Correspondence Address:
Nícollas Nunes Rabelo, Department of Neurosurgery, Atenas School of Medicine, Passos, Brazil.
DOI:10.25259/SNI_92_2024
Copyright: © 2024 Surgical Neurology International This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.How to cite this article: Salomon Soriano Ordinola Rojas1, Mateus Gonçalves de Sena Barbosa2, Amanda Ayako Minemura Ordinola1, Vinícius Otávio da Silva2, Rafaela Luiza Vilela de Souza2, Gustavo Frigieri3, Nícollas Nunes Rabelo2. Use of intracranial compliance to assist arterial blood pressure adjustment in critical patients: Short report and review of the literature. 16-Aug-2024;15:283
How to cite this URL: Salomon Soriano Ordinola Rojas1, Mateus Gonçalves de Sena Barbosa2, Amanda Ayako Minemura Ordinola1, Vinícius Otávio da Silva2, Rafaela Luiza Vilela de Souza2, Gustavo Frigieri3, Nícollas Nunes Rabelo2. Use of intracranial compliance to assist arterial blood pressure adjustment in critical patients: Short report and review of the literature. 16-Aug-2024;15:283. Available from: https://surgicalneurologyint.com/surgicalint-articles/13049/
Abstract
Background: Blood pressure management is extremely important to prevent cerebral hypoxia and influence the outcome of critically ill patients. In medicine, precise instruments are essential to increase patient safety in the intensive care unit (ICU), including intracranial compliance (ICC) monitoring. A new technology developed by Brain4care, makes it possible to analyze the waveform of intracranial pressure (ICP) non-invasively associated with ICC, and this instrument was used in the patient for monitoring.
Case Description: A 40-year-old male underwent aortic endocarditis surgery involving 182-min extracorporeal circulation and 9-min aortic clamping. Post-surgery, he exhibited a seizure bilateral mydriasis, followed by isochoric pupils and rapid foot movements. Neuroprotection measures were applied in the ICU, with noninvasive ICC monitoring initiated to assess intervention effectiveness.
Conclusion: The non-invasive measurement of ICP can help clinical decision-making regarding the optimization of adapted protocols for neuroprotection in the ICU.
Keywords: Arterial blood pressure, Critical patients, Intracranial compliance, Intracranial pressure, Monitoring
INTRODUCTION
The assessment to maintain adequate cerebral perfusion can be a challenge for patients with heart disease in an intensive care unit (ICU). The adjustment of arterial blood pressure (ABP) to supply the brain with adequate blood requires individualized analysis. Tools that allow precision performance medicine are essential to increase patient safety in the ICU. This report presents the use of a noninvasive technology for intracranial compliance (ICC) monitoring[
The intracranial pressure waveform (ICPwf) as a patient analysis mode offers more interesting data than just the intracranial pressure (ICP) cutoff value. The ICPwf is composed of 3 elements: P1 (cardiac systole), P2 (pulse wave in the blood), and P3 (venous return and diastole), and this waveform has been associated with cerebral compliance.[
CASE REPORT
A male, 40 years old, admitted to the hospital with aortic endocarditis, was submitted to a valved conduit exchange and coronary artery reimplantation. During the surgical procedure, he was maintained at extracorporeal circulation for 182 min, and the aorta was clamped for 9 min after 112 min from the beginning of surgery. This procedure has been associated with marked decreases in cerebral blood flow, stroke, and brain hypoxia.[
Methods
The patient was monitored with the non-invasive brain4care technology, which allows the analysis of the ICPwf, related to ICC.[
ICP measure technique
The use of ICPwf as a method for assessment and patient monitoring provides more detailed information than simply a fixed value of ICP. The ICPwf comprises three distinct components: P1, which is associated with cardiac systole; P2, which represents the pulse wave within the skull; and P3, related to venous return and diastole. Mosso[
RESULTS AND DISCUSSION
Immediately, post-seizure monitoring: indication of altered ICC with averaged ICPwf showing P2 > P1 (P2/P1 ratio = 1.29). Brain computed tomography showed diffuse cerebral edema, and electroencephalogram revealed diffuse disorganization. Transcranial Doppler assessments of the middle cerebral arteries (MCAs) revealed normal mean cerebral blood flow velocities (CBFVs) (98 cm/s and 78 cm/s for the right and left-brain hemispheres, respectively), without indication of microemboli or clear signs of intracranial hypertension but with varying mean CBFV in the MCAs which could be related to cerebral autoregulation impairment. To overcome the potential detrimental implications of dysfunctional autoregulation in cerebral perfusion pressure, we targeted systolic blood pressure at 140 mmHg and mean ABP at 100 mmHg. Medical management was characterized by sedation increase protocol and secondary cerebral ischemia prevention using vasoactive drugs to keep systolic blood pressure above 140 mmHg.
The second monitoring was made in 24 h after the first monitoring indicating ICC changed with P2 > P1, with marginal improvement of the P2/P1 ratio (P2/P1 = 1.21). Transcranial Doppler assessments of the cerebral arteries revealed different mean CBFVs. Medical management was the maintenance of sedation protocol and vasoactive drugs for neuroprotection. Blood pressure targets were established according to transcranial Doppler.
The third monitoring showed 24 h after the second monitoring indicated that ICC was improving, with a P2/P1 ratio under 1.0 (P2/P1 = 0.95). Medical management was maintenance sedation and vasoactive drugs. Another noninvasive ICP monitoring was requested after 48 hours.
The fourth monitoring was done after the third monitoring. The patient responded well to the neuroprotection management without any signs of intracranial edema on the tomography exam performed on the same day. The non-invasive ICP waveform normalized (P2/P1 = 0.88) and transcranial Doppler revealed normal mean CBFVs reaffirming that the clinical management by non-invasive monitorization might help physicians in decision-making in ICU.
The patient was extubated on the 5th day post-surgery without neurological symptoms.
In the prospective study conducted by Okon et al.,[
Fernandes et al.[
Kazimierska et al.[
At last, Westhout et al.[
The reviewed studies reveal important neuroprotective factors in various neurological conditions. In IIH, analysis of craniospinal compliance and CSF pressure waveform can guide management strategies. In renovascular hypertension, Angiotensin II and the AT1R receptor have been linked to increased ICP and disruption of the BBB. For normal pressure hydrocephalus, analysis of ICPwf amplitudes provides an effective method for monitoring CSF compliance. In traumatic brain injury, variations in ICPwf slope may indicate ICC loss, suggesting potential targets for neuroprotective interventions.
CONCLUSION
Cardiac surgeries are associated with intermittent brain hypoxia, which could lead to eventual cerebral edema and increased intracranial volume with consequent derangement of ICC. The technology used to monitor the ICC identified morphological changes in the ICPwf post-surgery and throughout the patient management in the ICU. The method could assist in clinical decision-making regarding the optimization of the protocols adapted for neuroprotection. Moreover, it is a non-invasive method to monitor the intracranial pressure (ICP) of patients with criteria and not mandatory, in a cheap, easy, and efficient way for diagnosis and treatment, whether in clinics or hospitals. Therefore, it is an innovative device that has a high capacity to reach many people because it is cheap and can positively impact the health and lives of many people.
Ethical approval
The Institutional Review Board approval is not required.
Declaration of patient consent
Patient’s consent was not required as there are no patients in this study.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Disclaimer
The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Journal or its management. The information contained in this article should not be considered to be medical advice; patients should consult their own physicians for advice as to their specific medical needs.
References
1. Andrade RA, Oshiro HE, Miyazaki CK, Hayashi CY, de Morais MA, Brunelli R. A nanometer resolution wearable wireless medical device for non invasive intracranial pressure monitoring. IEEE Sens J. 2021. 21: 22270-84
2. Ballestero MF, Frigieri G, Cabella BC, de Oliveira SM, de Oliveira RS. Prediction of intracranial hypertension through noninvasive intracranial pressure waveform analysis in pediatric hydrocephalus. Childs Nerv Syst. 2017. 33: 1517-24
3. Barber PA, Hach S, Tippett LJ, Ross L, Merry AF, Milsom P. Cerebral ischemic lesions on diffusion-weighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke. 2008. 39: 1427-33
4. Fernandes MV, Rosso Melo M, Mowry FE, Lucera GM, Lauar MR, Frigieri G. Intracranial pressure during the development of renovascular hypertension. Hypertension. 2021. 77: 1311-22
5. Frigieri G, Rabelo NN, de Sena Barbosa MG, Cagle Y, Pelligra R. Letter: Neurosurgery and manned spaceflight. Neurosurgery. 2021. 89: E91-2
6. Kazimierska A, Kasprowicz M, Czosnyka M, Placek MM, Baledent O, Smielewski P. Compliance of the cerebrospinal space: Comparison of three methods. Acta Neurochir. 2021. 163: 1979-89
7. Mosso A. Sulla circolazione del sangue nel cervello dell’uomo. Available from: https://philpapers.org/rec/mosscd [Last accessed on 2024 Feb 07].
8. Nunes Rabelo N, de Sena Barbosa MG, Silva Lemos MP, Brasil S, Frigieri G. Letter to the editor. Intracranial pressure monitoring: Challenge beyond the threshold numerical value. J Neurosurg. 2020. 134: 1682-3
9. Okon MD, Roberts CJ, Mahmoud AM, Springer AN, Small RH, McGregor JM. Characteristics of the cerebrospinal fluid pressure waveform and craniospinal compliance in idiopathic intracranial hypertension subjects. Fluids Barriers CNS. 2018. 15: 21
10. Rabelo NN, Chaves PH, de Sena Barbosa MG, Frigieri G. Is it possible to monitor the wave form with noninvasive methods?. World Neurosurg. 2021. 152: 231-2
11. Rabelo NN, de Sena Barbosa MG, Frigieri G. Letter to the editor regarding use of intracranial pressure monitoring in patients with severe traumatic brain injury. World Neurosurg. 2020. 143: 607
12. Westhout FD, Paré LS, Delfino RJ, Cramer SC. Slope of the intracranial pressure waveform after traumatic brain injury. Surg Neurol. 2008. 70: 70-4 discussion 74